Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG boosted its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 48.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,582 shares of the company’s stock after buying an additional 30,489 shares during the quarter. Deutsche Bank AG’s holdings in Alignment Healthcare were worth $1,053,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ALHC. Vanguard Group Inc. raised its holdings in shares of Alignment Healthcare by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company’s stock valued at $110,453,000 after buying an additional 166,837 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in shares of Alignment Healthcare by 54.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock valued at $97,302,000 after acquiring an additional 3,059,596 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the period. Hood River Capital Management LLC grew its stake in Alignment Healthcare by 39.6% during the 4th quarter. Hood River Capital Management LLC now owns 4,952,995 shares of the company’s stock worth $55,721,000 after purchasing an additional 1,405,212 shares in the last quarter. Finally, 8 Knots Management LLC increased its holdings in Alignment Healthcare by 49.5% during the 4th quarter. 8 Knots Management LLC now owns 3,658,695 shares of the company’s stock worth $41,160,000 after purchasing an additional 1,211,727 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Trading Down 0.1%

NASDAQ ALHC opened at $14.48 on Monday. The firm’s fifty day moving average price is $17.24 and its 200 day moving average price is $14.65. Alignment Healthcare, Inc. has a 12 month low of $6.92 and a 12 month high of $21.06. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The company has a market capitalization of $2.86 billion, a price-to-earnings ratio of -18.81 and a beta of 1.32.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. During the same quarter last year, the company posted ($0.25) earnings per share. The business’s quarterly revenue was up 47.5% compared to the same quarter last year. On average, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the company’s stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the sale, the director now directly owns 44,302,175 shares of the company’s stock, valued at approximately $676,937,234. This represents a 27.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Robert L. Scavo sold 2,864 shares of the business’s stock in a transaction dated Thursday, March 27th. The shares were sold at an average price of $17.89, for a total value of $51,236.96. Following the completion of the transaction, the insider now owns 702,953 shares in the company, valued at $12,575,829.17. This trade represents a 0.41% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,166,977 shares of company stock valued at $294,801,511. 7.00% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several recent research reports. Stifel Nicolaus lifted their price objective on Alignment Healthcare from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th. JPMorgan Chase & Co. lifted their price target on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. UBS Group increased their price objective on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a “neutral” rating in a research report on Friday, May 2nd. Piper Sandler raised their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Finally, Robert W. Baird boosted their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $17.17.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.